scout
|Articles|March 4, 2011

Oncology Nursing News

  • December 2010
  • Volume 4
  • Issue 6

Bone Loss Drugs Increase Stroke Risk in Patients With Cancer

Author(s)Onclive Team

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Articles in this issue

almost 15 years ago

Net Guides: Melanoma

almost 15 years ago

Net Guides: Bone Metastases

almost 15 years ago

Yoga for Cancer Care

almost 15 years ago

FDA Updates: March 7, 2011

almost 15 years ago

The Future of Nursing

almost 15 years ago

Net Guides: Liver Cancer

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME